Thalidomide in leprosy--study of 94 cases.

Abstract	Thalidomide has a beneficial effect on type II Lepra reaction especially chronic and recurrent reaction. It helps to minimise steroid dependency. Thalidomide was given to 94 cases of type II lepra reaction, who had not responded to steroids or had repeated reactions. This clinical data was analysed regarding clinical improvement, relapse of reaction, side effects of the drug, etc. The analysis showed that all the patients improved remarkably and steroids could be withdrawn. If the competence of staff using this drug is enhanced, morbidity due to leprosy can considerably be reduced.
Authors	D A Parikh, R Ganapati, C R Revankar
Journal	Indian journal of leprosy (Indian J Lepr) 1986 Oct-Dec Vol. 58 Issue 4 Pg. 560-6 ISSN: 0254-9395 [Print] India
PMID	3572098 (Publication Type: Journal Article)
Chemical References	Thalidomide Prednisolone Clofazimine
Topics	Adolescent Adult Clofazimine (therapeutic use) Humans Leprosy (drug therapy) Male Middle Aged Prednisolone (therapeutic use) Thalidomide (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!